Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Castro (St. Louis, United States of America), C. Humphries (Charlotte, United States of America), A. White (Port Orange, United States of America), C. Fox (Buffalo, United States of America), A. Rutgersson (Gothenburg, Sweden), M. Jörnten-Karlsson (Gothenburg, Sweden), B. Dutta (Gaithersburg, United States of America), L. Hagger (Gaithersburg, United States of America). Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control. 503

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Automated coaching for physical activity in COPD patients: results from a pilot study Source: International Congress 2017 – Innovation in pulmonary rehabilitation and chronic care Year: 2017 Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Late Breaking Abstract - Longitudinal analysis of variation in clinical features from the U-BIOPRED severe asthma cohort Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - Development of a multivariate model for clinical prediction in COVID 19 infected patients . Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021 Late Breaking Abstract: Is asthma really affecting your work? Respiratory work disability in a longitudinal population-based study Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease Year: 2010 Late Breaking Abstract - Reimbursement for asthma care is a universal barrier to achieving asthma symptom control: the SABINA III study Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Late Breaking Abstract: An animal model for studies on pathogenesis and pharmaceutical intervention of chronic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Late Breaking Abstract - IPF symptoms’ course during a 3-month observation: FIBRONET observational study’s preliminary results. Source: International Congress 2017 – Miscellaneous clinical problems Year: 2017 Late Breaking Abstract - A symptom-based algorithm to improve asthma diagnosis in early childhood:the CHILD Cohort Study Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019 Late Breaking Abstract - Efficacy and safety of tezepelumab in adults with severe asthma: A randomized phase 2 study Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Late Breaking Abstract - Childhood farming environment: Association to age at asthma diagnosis in a population-based study Source: Virtual Congress 2021 – New evidence from longitudinal asthma cohorts and other key studies Year: 2021 Late Breaking Abstract - Characterizing responders to benralizumab for severe asthma: pooled analysis of the SIROCCO and CALIMA studies Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Late Breaking Abstract - Predictive value of FeNO in patients with non-specific respiratory symptoms: a randomised controlled trial Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence Year: 2017 Late Breaking Abstract - Repeated cross-sectional epigenome-wide association study (EWAS) on lung function: the ALEC Project. Source: International Congress 2017 – Epigenetics of lung function Year: 2017 Late Breaking Abstract - Lung function tests in patients with previous SARS-COV2 pneumonia: a useful follow-up tool Source: Virtual Congress 2021 – Exacerbations of chronic respiratory diseases, including SARS-CoV-2 Year: 2021 Late Breaking Abstract - The TRITRIAL COPD study: preliminary baseline patient characteristics collected during the COVID-19 pandemic Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021 Late Breaking Abstract - ND-L02-s0201 treatment leads to efficacy in preclinical IPF models Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study Source: International Congress 2019 – Clinical approach to asthma management Year: 2019